FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 118 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q1 2024 | $1 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q4 2023 | $1 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q3 2023 | $1 | – | 138 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 138 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 138 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 138 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 138 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 138 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 138 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +300.0% | 138 | +165.4% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $70,091,000 | 17.54% |
| TRV GP IV, LLC | 2,343,154 | $41,450,000 | 11.92% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $3,538,000 | 1.49% |
| HighVista Strategies LLC | 89,963 | $1,591,000 | 1.27% |
| Logos Global Management LP | 685,000 | $12,118,000 | 1.25% |
| Monashee Investment Management LLC | 273,045 | $4,830,000 | 1.19% |
| RTW INVESTMENTS, LP | 3,866,872 | $68,405,000 | 1.00% |
| Parkman Healthcare Partners LLC | 250,106 | $4,424,000 | 0.98% |
| Deep Track Capital, LP | 750,000 | $13,268,000 | 0.94% |
| Darwin Global Management, Ltd. | 317,428 | $5,615,000 | 0.86% |